respiratory

News

GSK bolsters respiratory pipeline with Bellus Health buy

GSK has agreed to acquire Canada’s Bellus Health for around $2 billion, bolting on a late-stage drug candidate for chronic refractory cough.

News

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.

R&D

JP Morgan 2023 – Alexandre LeVert

Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs

News

How effective data management can support NHS Trusts to hit their targets

Roche, Boehringer tap biosensor firms for patient studies

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor te

News

Avillion, AstraZeneca asthma rescue treatment given FDA appr...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been

News

FDA clears Polarean's lung disease diagnostic Xenoview

US medtech company Polarean Imaging has secured FDA approval for Xenoview, a drug device combination used alongside magnetic resonance imaging (MRI) to measure how well the lungs are functi

GSK bolsters respiratory pipeline with Bellus Health buy

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

JP Morgan 2023 – Alexandre LeVert

Roche, Boehringer tap biosensor firms for patient studies

Avillion, AstraZeneca asthma rescue treatment given FDA appr...

FDA clears Polarean's lung disease diagnostic Xenoview

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

respiratory

Editor's Picks